10 May 2022
\n \n \n \nPint of Science is the world\u2019s largest public science festival bringing researchers to local pubs, cafes and spaces to share their scientific discoveries with the public.
\n \n\n \n \n5 May 2022
\n \n \n \nDPAG scientists across four research groups were highlighted at the major annual European Society of Cardiology basic science conference (FCVB 2022). Congratulations are in order for Dr KC Park on receiving the Young Investigator Award and to Dr Elisabetta Gamen on winning the Moderated Poster Prize.
\n \n\n \n \n13 April 2022
\n \n \n \nResearch led by Dr Alzbeta Hulikova and Professor Pawel Swietach has, for the first time, described the potential regulation of nuclear acid-base chemistry in neonatal and adult cardiomyocytes, and explained its relevance in the context of heart physiology and pathology.
\n \n\n \n \n16 March 2022
\n \n \n \nResearchers at the Cardiovascular Clinical Research Facility (CCRF) have won a five year MRC funding programme to help understand how high blood pressure (hypertension) during pregnancy affects the heart, brain and blood vessels throughout the life of women, as well as the children born after such a pregnancy.
\n \n\n \n \n7 March 2022
\n \n \n \nA new study involving Oxford Population Health researchers finds that both prevention and improved treatments have helped reduce deaths from heart attacks - but the relative importance of each varies by country, age and sex.
\n \n\n \n \n21 February 2022
\n \n \n \nThe wide-ranging effects of Long COVID and the associated issues for healthcare providers have been revealed in a new review of the major studies into the condition, which specifically highlights the impact of Long COVID on the cardiovascular system.
\n \n\n \n \n15 February 2022
\n \n \n \nAn Oxford BHF CRE \u201cPump Priming\u201d award to Professor Shoumo Bhattacharya and his research group led to a great return on investment with this exclusive licensing agreement for their innovative research.
\n \n\n \n \n14 February 2022
\n \n \n \nTwo projects aimed at tackling heart failure led by Associate Professor Sarah De Val and Dr Joaquim Vieira are to be funded by the 2022 TCS London Marathon with the British Heart Foundation as its Charity of the Year. The BHF\u2019s runners, who are raising \u00a33 million in funding, will include De Val Lab postdoctoral researcher Dr Alice Neal.
\n \n\n \n \n11 February 2022
\n \n \n \nCongratulations to Jillian, who has begun her Oxford BHF CRE Transition Fellowship, focusing on nutrient sensing and signalling in the heart by PKA-RI\u03b1 (or type-1 PKA)
\n \n\n \n \n8 February 2022
\n \n \n \nMany congratulations to Dr Qiang Zhang, Oxford BHF CRE Transition Fellow, who has won a prestigious award for his work in developing a groundbreaking technology for detecting scar in the myocardium
\n \n\n \n \n3 February 2022
\n \n \n \nCongratulations to Dr Filipa Sim\u00f5es, previous holder of an Oxford BHF CRE Transition Fellowship, who has been awarded a prestigious BHF Intermediate Research Fellowship to establish her exciting research programme into the regenerating heart at the new Oxford Institute of Developmental and Regenerative Medicine (IDRM) in Spring 2022. Good luck Filipa!
\n \n\n \n \n1 February 2022
\n \n \n \n\n \n \n1 February 2022
\n \n \n \n\n \n \n25 November 2021
\n \n \n \nScientists have shed light on an important stage of early embryonic development that has never been fully mapped out in humans before.
\n \n\n \n \n29 October 2021
\n \n \n \n\n \n \n29 October 2021
\n \n \n \nThe Radcliffe Department of Medicine\u2019s Dr Betty Raman is leading a new a phase 2a clinical trial to investigate whether a drug could treat the fatigue and muscle weakness experienced by many patients who have recovered from COVID.
\n \n\n \n \n20 October 2021
\n \n \n \nNew research led by Associate Professor Lisa Heather has found that a drug known as molidustat, currently in clinical trials for another condition, could reduce risk of heart failure after heart attacks.
\n \n\n \n \n14 September 2021
\n \n \n \nDr Richard Tyser is this year\u2019s winner of the Bernard and Joan Marshall Early Career Investigator Prize, and Dr Jack Miller has received a runner-up award, at the British Society of Cardiovascular Research Autumn Meeting.
\n \n\n \n \n25 August 2021
\n \n \n \nDPAG Postdoctoral Research Scientist Dr Xin Sun has been shortlisted in the British Heart Foundation\u2019s (BHF) annual \u2018Reflections of Research\u2019 image competition.
\n \n\n \n \n29 July 2021
\n \n \n \nNew research from the Heather Group has shown that in type 2 diabetes an overload of lipids reduces the heart\u2019s ability to generate energy during a heart attack, decreasing chances of recovery.
\n \n\n \n \n